Pacer Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.56M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.32M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.09M | Buy |
|
|||||
|
2021
Q1 | $528K | Buy |
|
|||||
|
2020
Q4 | $47K | Buy |
|
|||||
|
2020
Q3 | $38K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $87K | Sell |
|
|||||
|
2019
Q4 | $343K | Sell |
|
|||||
|
2019
Q3 | $363K | Buy |
|
|||||
|
2019
Q2 | $301K | Buy |
|
|||||
|
2019
Q1 | $230K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $165K | Buy |
|
|||||
|
2018
Q2 | $65K | Buy |
|
|||||
|
2018
Q1 | $19K | Sell |
|
|||||
|
2017
Q4 | $77K | Buy |
|
|||||
|
2017
Q3 | $30K | Buy |
|